Peer-reviewed veterinary case report
Effectiveness of boric acid ear drops for dog ear infections
By Ünlü, Elif·Published in Veterinary research communications·2025·Department of Surgery·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical, cytological, and microbiological evaluation of a topical boric acid-alcohol solution for the treatment of canine otitis externa: a randomized, open-label controlled clinical trial.
- Species:
- dog
Plain-English summary
A group of dogs with ear infections (otitis externa) was treated with a topical solution made of boric acid and alcohol, while another group received a commercial ear cleaner. After 14 days, 93.3% of the dogs treated with the boric acid-alcohol solution showed significant improvement, compared to only 26.7% in the other group. The boric acid solution not only helped clear up the infection but also eliminated common bacteria and fungi causing the problem. This treatment proved to be effective and may help reduce the need for more aggressive medications.
People also search for: dog ear infection treatment · boric acid for dog ears · commercial ear cleaner for dogs
Abstract
Otitis externa (OE) is a common inflammatory condition frequently encountered in veterinary practice. This study aimed to evaluate the efficacy of a topical 5% boric acid-alcohol (BAA) solution compared to a commercial ear cleanser (EpiOtic) for treating canine OE. Thirty client-owned dogs with OE were enrolled in a randomized, open-label controlled clinical trial and assigned to two treatment groups: Group I received BAA combined with EpiOtic, and Group II received EpiOticalone, both applied twice daily for 14 days. Clinical assessments-including OTIS-3 scoring, secretion type, otoscopic findings, pain, pruritus, and cytology-were performed on days 0, 7, 14, and 21, with microbiological analyses on days 0 and 21. By day 21, treatment success was achieved in 93.3% of Group I dogs, compared to 26.7% in Group II (p < 0.001). Group I showed significant improvements in all clinical parameters (p ≤ 0.001), while Group II exhibited only modest changes. Cytology showed significantly better results in Group I on days 7 (p = 0.002), 14, and 21 (both p < 0.001), with cytological success rates of 93.3% vs. 20% in Group II. By day 21, microbiological analysis demonstrated complete fungal eradication and near-complete bacterial clearance in Group I, with cultures confirming elimination of common pathogens including Staphylococcus intermedius, Proteus mirabilis, Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Malassezia pachydermatis. These findings indicate that BAA is a safe, effective, and economical alternative for managing canine OE and may contribute to antimicrobial stewardship by reducing the need for systemic therapies.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40986202/